Medplus Health Stock: Q4 Mein Profit **24.6%** Bhaga, Revenue Bhi **23.5%** Bada!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Medplus Health Stock: Q4 Mein Profit **24.6%** Bhaga, Revenue Bhi **23.5%** Bada!
Overview

Arre bhai, Medplus Health Services ne Q4 mein kamaal kar diya! Profit **24.6%** jump karke **₹63.97 Crore** ho gaya aur revenue bhi **23.5%** badh kar **₹1,864.39 Crore** pahunch gaya. Sab operational efficiency aur **5.8%** EBITDA margin ki wajah se hai. Company ab aur stores kholne mein lagi hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Profit aur Revenue Mein Toofani Tezi!

Medplus Health Services ka Q4 result ekdum zabardast raha! March 2026 tak ke quarter mein, company ka net profit 24.6% badh gaya, jo ₹51.32 Crore se ₹63.97 Crore ho gaya. Aur suno, revenue from operations bhi 23.5% chadh gaya, ₹1,509.6 Crore se ₹1,864.39 Crore tak! Stock 11% se zyada bhaga, sab is performance ki wajah se.

Strategic Position Aur Margins Ki Baat

India ki doosri sabse badi pharmacy retailer hone ke naate, Medplus Health Services ekdum sahi position mein hai. Indian pharmacy market toh $50.88 Billion tak pahunchne wala hai 2032 tak! Company ki operational efficiency dekho, EBITDA margin 5.3% se sudhar kar 5.8% ho gaya hai. Analysts bhi 'Strong Buy' keh rahe hain aur average price target ₹1,118 diya hai. 5,000+ stores aur omni-channel strategy toh inki USP hai.

Competition Aur Risks Bhi Hain

Par bhai, Indian pharmacy market mein bahot competition hai, Apollo Pharmacy jaise bade players bhi hain. Medplus ka growth store expansion pe depend karta hai, jismein risks ho sakte hain. Margins sudhre hain, par operating costs badh rahe hain aur price sensitivity bhi ek issue hai. Analysts ko Q4 mein same-store sales growth mein kami dikhi aur ek-ek baar ka expense bhi hua tha. P/E ratio 54.19 aur PEG ratio 3.95 dekh kar kuch investors ko valuation thoda mehnga lag sakta hai.

Future Growth Ke Liye Kya Plan Hai?

Medplus Health Services ko lagta hai ki growth chalta rahega. FY25 mein 600+ naye stores kholne ka plan hai aur private-label products ka share bhi badhana hai. Management efficiency aur supply chain pe focus kar raha hai taaki margins aur badhen. Next three years mein 12% annual revenue growth ka target hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.